Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-060116

Chief Operating Officer sold 3,125 shares at an average $33.16 ($103,630)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ADAMS R MARK Chief Operating Officer 2021-10-07 Sale −1,324 $32.47 $42,990 53,655 D: show line 1 in the form
ADAMS R MARK Chief Operating Officer 2021-10-08 Sale −1,801 $33.67 $60,640 51,854 D: show line 2 in the form
Open-market sales · 3,125 sh · avg $33.16 · $103,630
Loading xslF345X03/doc4.xml…